A recently published study by NDEWS Deputy Director Dr. Joseph Palamar examined trends in awareness that cocaine can be adulterated with fentanyl among nightclub and festival attendees in New York City. Results suggest that knowledge that cocaine can be adulterated with fentanyl is increasing in this high-risk population. Dr. Palamar…
Joseph Palamar, PhD, MPH, Associate Professor, Department of Population Health at NYU Langone Medical Center, has been named Deputy Director of NDEWS. He is a Co-Investigator in our NIDA-funded U01 study, he serves as chair of the Scientific Advisory Group, and has been researching the epidemiology of drug use for over…
A study published in Drug and Alcohol Dependence by NDEWS researchers, led by Co-Investigator Dr. Joseph Palamar, examined quarterly national seizure data from High Intensity Drug Trafficking Areas to determine the number of drug seizures in the US containing fentanyl from January 2018 through December 2021. Read the full study here.For…
In July 2021, the NDEWS Coordinating Center was awarded two administrative supplements from the National Institute on Drug Abuse to expand our efforts to monitor new and emerging drug trends through two new initiatives: wastewater-based epidemiology and national Poison Control data. Led by Dr. Tara Sabo-Atwood, the wastewater-based epidemiology initiative…
A new NDEWS paper, in collaboration with NPS Discovery, is now available in International Journal of Drug Policy. Led by NDEWS Co-I Dr. Elan Barenholtz and Dr. Alex Krotulski from NPS Discovery, the study evaluated the utility of using drug-related Reddit forums as an early indicator of future…
A new analysis of law enforcement drug seizures in five key regions of the United States, led by NDEWS Co-Investigator Dr. Joseph Palamar, found an increase in methamphetamine and marijuana confiscations during the COVID-19 pandemic. Investigators examined trends in seizures of marijuana, cocaine, methamphetamine, heroin, and fentanyl within five High…
NDEWS was first funded by the National Institute on Drug Abuse (NIDA) in 2014 to expand the longstanding Community Epidemiology Workgroup (CEWG). In April 2020, the second iteration of the NIDA-funded NDEWS was awarded to our team from the University of Florida, New York University, and Florida Atlantic University. NDEWS…
NDEWS Co-Investigator Dr. Bruce Goldberger and NDEWS Scientific Advisory Group Member Dr. Barry Logan, along with other collaborators at NMS Labs and the Center for Forensic Science Research and Education, recently published an article on the synthetic cathinone eutylone (bk-EBDB), which was identified in 83 forensic investigations from thirteen states.
NDEWS Principal Investigator Dr. Linda B. Cottler, co-editor of Addictive Disorders for Current Opinion in Psychiatry, invited articles in the July 2020 issue on new psychoactive substances (NPS) and approaches to drug monitoring, including a description of the NDEWS effort from our predecessors at the University of Maryland.
NDEWS Co-Investigator Dr. Joseph Palamar discusses the re-emergence of gamma-hydroxybutyric acid (GHB) with NBC News in a new article.
